Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Study of Letrozole With or Without BYL719 or Buparlisib, for the Neoadjuvant Treatment of Postmenopausal Women

Novartis Pharmaceuticals · 2014
ClinicalTrials.gov · Datasets · License: Public Domain · 2014
Open Source ↗
breast-cancer
breast cancer, byl719, alpelisib, bkm120, buparlisib, pathological complete response, neoadjuvant, hormone receptor-positive, her2 negative, objective response rate, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 879108
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.